Clincosm LogoSign in Get a demo

Leukemia

Showing NaN - NaN of 143
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +175 more
Aug 16, 2021

Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
Has Results
  • Leukemia
  • Lymphoma
  • rituximab
  • +7 more
  • Duarte, California
  • +24 more
Aug 16, 2021

Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Active, not recruiting
  • Leukemia
  • +2 more
  • laboratory biomarker analysis
  • San Diego, California
  • +50 more
Aug 16, 2021

Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

Completed
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +197 more
Mar 22, 2021

Leukemia, Myelodysplastic Syndrome Trial in Boston, Saint Louis (AZD6738)

Recruiting
  • Leukemia
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +3 more
Jan 13, 2021

Lymphoma, Leukemia, Multiple Myeloma Trial in Australia, Germany, United States (LBH589)

Completed
Has Results
  • Lymphoma
  • +2 more
  • Augusta, Georgia
  • +6 more
Dec 16, 2020

Leukemia Trial in Israel, United States (biological, drug, procedure)

Completed
Has Results
  • Leukemia
  • sargramostim
  • +7 more
  • Birmingham, Alabama
  • +98 more
Oct 23, 2020

Leukemia Trial in Boston (GM-K562 cell vaccine, imatinib mesylate)

Completed
  • Leukemia
  • GM-K562 cell vaccine
  • imatinib mesylate
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 26, 2020

Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

Completed
  • Breast Carcinoma
  • +12 more
  • Management of Therapy Complications
  • +3 more
  • Los Angeles, California
  • +5 more
Oct 8, 2020

Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

Active, not recruiting
  • Leukemia
  • Azacitidine (AZA) Days 1 - 3
  • +3 more
  • Tampa, Florida
  • +5 more
Jul 21, 2020

Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Canada, United States (EPZ-5676)

Completed
  • Leukemia
  • +3 more
  • Los Angeles, California
  • +8 more
May 7, 2020

Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

Terminated
Has Results
  • Leukemia
  • rituximab
  • fludarabine phosphate
  • Anniston, Alabama
  • +386 more
Apr 9, 2020

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)

Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
Nov 25, 2019

Leukemia Trial in Worldwide (biological, drug, procedure)

Unknown status
  • Leukemia
  • anti-thymocyte globulin
  • +21 more
  • Boston, Massachusetts
  • +12 more
Jul 29, 2019

Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • anti-thymocyte globulin
  • +7 more
  • Los Angeles, California
  • +5 more
Jul 1, 2019

Leukemia Trial in Worldwide (Midostaurin (PKC412))

Completed
Has Results
  • Leukemia
  • Midostaurin (PKC412)
  • Los Angeles, California
  • +28 more
Oct 16, 2018

Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with

Completed
Has Results
  • Aplastic Anemia
  • +2 more
  • Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
  • CliniMACS device
  • Boston, Massachusetts
  • +5 more
Jun 14, 2018

Leukemia Trial in Germany, United States (Atuveciclib, BAY1143572)

Completed
  • Leukemia
  • Atuveciclib, BAY1143572
  • Boston, Massachusetts
  • +6 more
Jun 21, 2018

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (MEDI-507, Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant)

Terminated
  • Lymphoma
  • +3 more
  • MEDI-507
  • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 14, 2018

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant, T-cell depleted

Terminated
  • Lymphoma
  • +3 more
  • Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
  • T-cell depleted peripheral blood stem cell transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 14, 2018

Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic

Completed
Has Results
  • Leukemia
  • +2 more
  • Allogeneic bone marrow transplantation
  • Peripheral blood stem cell transplantation
  • Birmingham, Alabama
  • +44 more
Oct 24, 2017

Leukemia, Acute Disease, Acute Myeloid Leukemia Trial in United States (vosaroxin)

Completed
Has Results
  • Leukemia
  • +4 more
  • Phoenix, Arizona
  • +19 more
May 25, 2017

Prostate Cancer, Breast Cancer, Lung Cancer Trial in United States (internet-based intervention, assessment of therapy

Completed
  • Prostate Cancer
  • +5 more
  • internet-based intervention
  • +2 more
  • Castro Valley, California
  • +94 more
Jun 26, 2017

Leukemia Trial in Boston (CD 40)

Terminated
  • Leukemia
  • CD 40
  • Boston, Massachusetts
  • +1 more
Jun 19, 2017

Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Umbilical Cord Blood After Myeloablative Conditioning, Umbilical Cord

Terminated
Has Results
  • Leukemia
  • +3 more
  • Umbilical Cord Blood After Myeloablative Conditioning
  • Umbilical Cord Blood After Reduced-Intensity Conditioning
  • Boston, Massachusetts
    Tufts Medical Center
May 1, 2017